Anti-diabetic, Anti-cancer Activity and Associated Toxicity of Leucas aspera Extract in Wistar Albino Rats
Abstract
In regenerative medicine, nanotechnology plays a vital role in the diagnosis, the delivery of therapeutic drugs and the treatment of many diseases and disorders. Due to the growing need to develop environmentally friendly technologies in material synthesis, the biosynthesis of Iron Oxide Nanoparticles (IOP) has received considerable attention over the past decades. Therefore, the community is now looking back for traditional medicines for various diseases after the practice of allopathic drugs with tremendous side effects. There are an increasing number of biomedical applications for iron oxide nanoparticles; as such uses are essential for in-vitro characterisation and in-vivo to ensure the bio-safety of these particles. The main complication of diabetes due to frequent lipid peroxidation is liver damage and renal dysfunction, but treatment with Leucas aspera has a pronounced effect on these indicators, which protects the organs from further damage. The current research supports the traditional use of Leucas aspera against diabetes mellitus and cancer, as well as the safety, effectiveness and potency of Leucas aspera leaf extract's anti-diabetic and anti-cancer effect in the in-vivo model. The overall results reveal that Leucas aspera has the potential and can be a candidate of choice without side effect.
Keywords:
Anti-diabetic activity, Diabetes mellitus, Iron oxide nanoparticles (IOP), Leucas aspera, Toxicity studies.DOI
https://doi.org/10.25004/IJPSDR.2019.110617References
Taofik O Sunmonu and Anthony J Afolayan. Evaluation of anti-diabetic activity and associated toxicity of artemisia afra aqueous extract in Wistar rats. Evidence-Based Complementary and Alternative Medicine. 2013; Article ID 929074: 1-8.
Sidhra SZA, Syed ZAK, Krishnaveni R, Anupriya B, Senthil KB, Kishore RK. Modulatory effect of Leucas aspera on oxidative stress and glucose metabolism against diabetic complications in experimental rats. International Research Journal of Pharmacy. 2017; 8(8):27-33.
Srinivasan R, Ravali B, Suvarchala P, Honey A, Tejaswini A, Neeraja P. Leucas aspera - Medicinal plant: A review, International Journal of Pharma and Biosciences. 2011; 2(1): 153-159.
Abdul M, Hirak D, Mohibur R, Jerin J, Aziza S, Mahabuba R, Shahnaz R, Majeedul H.C, Mohammed R. Anti-hyperglycemic activity evaluation Leucas aspera (Wild.) Link leaf and stem and Lannea coromandelica (Houtt.) Merr. Bark extract in mice. Advances in Natural and Applied Sciences. 2010; 4(3): 385-388.
Veeramanikandan V, Madhu G, Pavithra V, Jaianand K and Balaji P. Green synthesis, characterization of iron oxide nanoparticles using Leucas aspera leaf extract and evaluation of antibacterial and antioxidant studies. International Journal of Agriculture Innovations and Research. 2017; 06(02):242-250.
Madhu GC, Jaianand K, Rameshkumar K, Balaji P, Veeramanikandan V. In-vivo studies on anti-diabetic potential of Leucas aspera in streptozotocin induced diabetic wistar albino rats. Journal of Drug Delivery and Therapeutics. 2019; 9(4-s):105-110.
Ecobichon DJ. The basis of toxicology testing. CRC Press, New York, 1997; Pp. 43-86.
Subhan AM, Shaik AN, Saritha M, Krishna TT, Malaka VJK, Chippada AR. Phytochemical screening and anti-hyperglycemic activity of Heliotropium indicum whole plant in Streptozotocin induced diabetic rats. Journal of Applied Pharmaceutical Science. 2014; 4 (12): 65-71.
Madhu GC, Jaianand K, Rameshkumar K, Eyini M, Balaji P, Veeramanikandan V. Solanum Tuberosum extract mediated synthesis and characterization of iron oxide nanoparticles for their antibacterial and antioxidant activity. Journal of Drug Delivery and Therapeutics. 2019; 9(1):5-15.
Published
Abstract Display: 576 
PDF Downloads: 968 
